David Kim1, Kethy Jules-Elysee1, Lauren Turteltaub1, Michael K Urban1, Jacques T YaDeau1, Shane Reid1, Stephen Lyman2, Yan Ma3. 1. Department of Anesthesiology, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021 USA. 2. Department of Anesthesiology, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021 USA ; Division of Biostatics and Epidemiology, Department of Public Health, Weill Cornell Medical College, New York, NY 10065 USA. 3. Division of Biostatics and Epidemiology, Department of Public Health, Weill Cornell Medical College, New York, NY 10065 USA.
Abstract
BACKGROUND: Pulmonary hypertension (PH) is regarded as a risk factor for perioperative complications in patients undergoing noncardiac surgery. QUESTIONS/PURPOSES: The objective of this retrospective case-control study was to evaluate the adverse outcomes of pulmonary hypertension patients undergoing elective unilateral hip replacements. METHODS: We performed a retrospective case-control study of total hip replacement patients with pulmonary hypertension (cases) and without pulmonary hypertension (control). From the years 2003 to 2008, we identified a total of 132 patients undergoing primary total hip replacements with a diagnosis of pulmonary hypertension (right ventricular systolic pressure >35). The primary outcome assessed was the incidence of adverse events that occurred during the postoperative hospital stay. Secondary outcomes studied included length of hospital stay, mortality, and ability to reach certain physical therapy milestones. RESULTS: The PH group had significantly more adverse events than the control group. Nonlethal cardiac dysrhythmias comprised the most common adverse outcome among the PH group. Overall, the PH group had a morbidity rate of 34.7% while the control had a rate of 21%. The PH group had longer hospital stay (6.7 days vs. 5.9). Both groups had zero mortality during the hospital stay. The PH group had comparable rehabilitation recovery times than the control group. CONCLUSION: This retrospective case-control study demonstrates that pulmonary hypertension patients undergoing total hip arthroplasty are more prone to adverse outcomes, especially cardiac dysrhythmias, and longer hospital stays.
BACKGROUND:Pulmonary hypertension (PH) is regarded as a risk factor for perioperative complications in patients undergoing noncardiac surgery. QUESTIONS/PURPOSES: The objective of this retrospective case-control study was to evaluate the adverse outcomes of pulmonary hypertensionpatients undergoing elective unilateral hip replacements. METHODS: We performed a retrospective case-control study of total hip replacement patients with pulmonary hypertension (cases) and without pulmonary hypertension (control). From the years 2003 to 2008, we identified a total of 132 patients undergoing primary total hip replacements with a diagnosis of pulmonary hypertension (right ventricular systolic pressure >35). The primary outcome assessed was the incidence of adverse events that occurred during the postoperative hospital stay. Secondary outcomes studied included length of hospital stay, mortality, and ability to reach certain physical therapy milestones. RESULTS: The PH group had significantly more adverse events than the control group. Nonlethal cardiac dysrhythmias comprised the most common adverse outcome among the PH group. Overall, the PH group had a morbidity rate of 34.7% while the control had a rate of 21%. The PH group had longer hospital stay (6.7 days vs. 5.9). Both groups had zero mortality during the hospital stay. The PH group had comparable rehabilitation recovery times than the control group. CONCLUSION: This retrospective case-control study demonstrates that pulmonary hypertensionpatients undergoing total hip arthroplasty are more prone to adverse outcomes, especially cardiac dysrhythmias, and longer hospital stays.
Entities:
Keywords:
outcomes; perioperative complications; pulmonary hypertension; total hip arthroplasty
Authors: Stavros G Memtsoudis; Yan Ma; Ya Lin Chiu; J Matthias Walz; Robert Voswinckel; Madhu Mazumdar Journal: Anesth Analg Date: 2010-09-14 Impact factor: 5.108
Authors: Gautam Ramakrishna; Juraj Sprung; Barugur S Ravi; Krishnaswamy Chandrasekaran; Michael D McGoon Journal: J Am Coll Cardiol Date: 2005-05-17 Impact factor: 24.094
Authors: Hussein J Hassan; Traci Housten; Aparna Balasubramanian; Catherine E Simpson; Rachel L Damico; Stephen C Mathai; Paul M Hassoun; Jochen Steppan; Peter J Leary; Todd M Kolb Journal: ERJ Open Res Date: 2021-07-19